Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Biotechnol Lett ; 28(4): 267-70, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16555011

ABSTRACT

A modified procedure of cDNA-amplified fragment length polymorphism (cDNA-AFLP) combined with silver staining is described which generates clear band patterns from both fungal total RNA and poly-A RNA. The silver staining procedure takes only 25 min. Some 42-55 transcript-derived fragments (TDFs) were yielded from the total RNA of eight fungal pathogens. In comparison with the fingerprints generated from Mycosphaerella graminicola total RNA, those from poly-A RNA showed eight TDFs with an increased intensity and also seven additional TDFs. It suggests that poly-A RNA is preferable as starting material for ideal cDNA-AFLP analysis.


Subject(s)
Comet Assay/methods , DNA Fingerprinting/methods , DNA, Complementary/genetics , Polymorphism, Restriction Fragment Length , RNA, Fungal/analysis , RNA, Fungal/genetics , Silver Staining/methods , RNA, Messenger/analysis , RNA, Messenger/genetics
2.
Biotechnol Lett ; 27(1): 3-6, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15685411

ABSTRACT

A modified procedure using the commercial DNAzol reagent was successfully applied to extract genomic DNA from 25 fungal species. The DNA yield varied from 306 to 1,927 microg g(-1) dry mycelia and the A(260)/A(280) ratio from 1.59 to 1.93. Compared with the method of J.L. Cenis (Nucleic Acids Res. 1992, 20: 2380) this procedure generated a higher DNA yield from 17 species and a higher A(260)/A(280) ratio from 23 species. But for four species, Cenis (1992) method was more suitable. No inhibitor of polymerase chain reaction was evident for the DNA extracted by the modified procedure, whereas some inhibitors remained in DNA of eight species extracted by the previous method.


Subject(s)
DNA, Fungal/isolation & purification , Fungi/genetics , Indicators and Reagents/chemistry , Base Sequence , DNA Primers , Electrophoresis, Agar Gel
3.
Int J Antimicrob Agents ; 22(5): 487-91, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14602366

ABSTRACT

Results of antimicrobial sensitivity tests for strains of Salmonella enterica serotypes Typhi and Paratyphi A isolated from patients in ten European countries between 1999 and 2001 have been transferred electronically to the Enter-net surveillance hub. For Typhi between 22 and 29% of isolates were multiresistant (to four drugs or more) with decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/l) increasing from 20% in 1999 to 26% in 2001. Nineteen of 169 (11%) strains with decreased ciprofloxacin susceptibility were sensitive to nalidixic acid. For Paratyphi A multiple resistance increased from 9% in 1999 to 25% in 2001 and decreased ciprofloxacin susceptibility from 6 to 17%. Clinicians should be aware of the possibility of treatment failures when fluoroquinolones are used as the first-line drug for infections with Typhi and Paratyphi A, particularly for patients recently returning from areas where drug-resistant strains are endemic.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Salmonella Infections/microbiology , Salmonella enterica/drug effects , Ciprofloxacin/pharmacology , Europe , Humans , Microbial Sensitivity Tests , Salmonella enterica/classification , Salmonella enterica/isolation & purification , Serotyping
4.
Euro Surveill ; 8(2): 41-5, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12631974

ABSTRACT

The Enter-net surveillance system received results of antimicrobial sensitivity tests for isolates from over 27 000 cases of human salmonellosis in 2000 in 10 European countries. Almost 40% of isolates were resistant to at least one antimicrobial, with 18% multiresistant. Resistance to ampicillin, streptomycin, sulphonamides and tetracyclines was common, with over 20% of isolates resistant to at least one of these antimicrobials. Clinical resistance to ciprofloxacin was rare, with only 0.5% of isolates exhibiting such resistance (MIC >1.0 mg/l). Resistance to nalidixic acid coupled with a decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/l) was more common, with 14% of isolates showing these properties. Resistance to third-generation cephalosporins was rare with only 0.6% of isolates resistant to cefotaxime. In all countries multiple resistance was most common in Salmonella enterica serotype Typhimurium, with 51% of isolates multiresistant in total. In England and Wales multiple resistance was also prevalent in S. Virchow and S. Hadar, whereas in other countries multiple resistance was common in serotypes such as S. Blockley.


Subject(s)
Anti-Bacterial Agents/pharmacology , Salmonella Infections/microbiology , Salmonella enterica/drug effects , Drug Resistance, Bacterial , Europe/epidemiology , Humans , Population Surveillance , Salmonella Infections/drug therapy , Salmonella enterica/classification , Salmonella enterica/isolation & purification , Serotyping
SELECTION OF CITATIONS
SEARCH DETAIL
...